Cormedix Inc (CRMD)

1.50
0.05 3.45
AMEX : Health Care
Prev Close 1.45
Open 1.47
Day Low/High 1.47 / 1.55
52 Wk Low/High 1.15 / 4.54
Volume 589.74K
Avg Volume 331.40K
Exchange AMEX
Shares Outstanding 36.22M
Market Cap 50.71M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

CorMedix Inc. To Present Post-Market Clinical Utility Data From Neutrolin® Usage Monitoring Program On May 23, 2016

CorMedix Inc. To Present Post-Market Clinical Utility Data From Neutrolin® Usage Monitoring Program On May 23, 2016

Data to be Presented at the 53rd Joint Congress of the European Renal Association - European Dialysis and Transplant Association

CorMedix To Present At National Kidney Foundation® 2016 Spring Clinical Meetings

CorMedix To Present At National Kidney Foundation® 2016 Spring Clinical Meetings

Abstract to be Published in Peer-Reviewed American Journal of Kidney Diseases

Pacific Premier Bancorp, Inc. Announces The Appointment Of New Director

Pacific Premier Bancorp, Inc. Announces The Appointment Of New Director

Pacific Premier Bancorp, Inc. (NASDAQ: PPBI) (the "Company", "Pacific Premier", "we", "us" or "our"), the holding company of Pacific Premier Bank ("Pacific Premier Bank"), announced today the expansion of its Board of...

4 Stocks Under $10 to Trade for Big Breakouts

4 Stocks Under $10 to Trade for Big Breakouts

These stocks under $10 are within range of triggering breakout trades.

Law Offices Of Howard G. Smith Reminds Investors: Two Days Left To File Lead Plaintiff Motion In The Class Action Lawsuit Against CorMedix, Inc.

Law Offices Of Howard G. Smith Reminds Investors: Two Days Left To File Lead Plaintiff Motion In The Class Action Lawsuit Against CorMedix, Inc.

Law Offices of Howard G. Smith reminds investors of the September 4, 2015 lead plaintiff deadline in the class action lawsuit filed on behalf of a class comprising purchasers of the securities of CorMedix, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of CorMedix, Inc.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against CorMedix, Inc. And Encourages Investors To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against CorMedix, Inc. And Encourages Investors To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey against CorMedix, Inc.

GPM Reminds Investors Of The September 4, 2015 Deadline In The Class Action Lawsuit On Behalf Of CorMedix, Inc. Investors

GPM Reminds Investors Of The September 4, 2015 Deadline In The Class Action Lawsuit On Behalf Of CorMedix, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") reminds investors that a class action lawsuit has been filed on behalf of investors of CorMedix, Inc.

GPM Announces The Filing Of A Securities Class Action On Behalf Of CorMedix, Inc. Investors

GPM Announces The Filing Of A Securities Class Action On Behalf Of CorMedix, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") announces the filing of a class action lawsuit on behalf of investors of CorMedix, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of CorMedix, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of September 4, 2015

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of CorMedix, Inc.

3 Stocks Under $10 Making Big Moves

3 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

CorMedix Stock Sees Short Interest Expand By 40%

CorMedix Stock Sees Short Interest Expand By 40%

The most recent short interest data has been released by the NASDAQ for the 07/15/2015 settlement date, which shows a 1,754,347 share increase in total short interest for CorMedix Inc , to 6,132,421, an increase of 40.07% since 06/30/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Interesting CRMD Put And Call Options For March 2016

Interesting CRMD Put And Call Options For March 2016

Investors in CorMedix Inc saw new options become available this week, for the March 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TRADING ALERT: The Rosen Law Firm Reminds CorMedix, Inc. Investors Of The Important Deadline In The Class Action

TRADING ALERT: The Rosen Law Firm Reminds CorMedix, Inc. Investors Of The Important Deadline In The Class Action

The Rosen Law Firm, a global investor rights firm, reminds purchasers of CorMedix, Inc.

EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Lawsuit Against CorMedix, Inc. To Recover Investor Losses

EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Lawsuit Against CorMedix, Inc. To Recover Investor Losses

The Rosen Law Firm, a global investor rights firm, announces that a class action lawsuit has been filed on behalf of purchasers of CorMedix, Inc.

CRMD INVESTOR ALERT: Investigation Of CorMedix, Inc., Announced By Glancy Prongay & Murray LLP

CRMD INVESTOR ALERT: Investigation Of CorMedix, Inc., Announced By Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP announces that it is investigating potential claims on behalf of investors of CorMedix, Inc.

Cormedix (CRMD): Today's Weak On High Volume Stock

Cormedix (CRMD): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Cormedix (CRMD) as a weak on high relative volume candidate

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against CorMedix, Inc. - CRMD

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against CorMedix, Inc. - CRMD

The Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of investors of CorMedix, Inc.

Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!

Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!

Biotech columnist Adam Feuerstein answers readers' questions about health care.